Pfm Health Sciences, LP Xenon Pharmaceuticals Inc. Transaction History
Pfm Health Sciences, LP
- $1.71 Billion
- Q3 2024
A detailed history of Pfm Health Sciences, LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 179,878 shares of XENE stock, worth $7.2 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
179,878
Previous 150,554
19.48%
Holding current value
$7.2 Million
Previous $5.87 Million
20.58%
% of portfolio
0.42%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.5MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$227 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$184 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$154 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$108 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$108 Million9.03% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.49B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...